WallStreetZenWallStreetZen

NASDAQ: RNA
Atrium Therapeutics Inc Stock Ownership - Who owns Atrium Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Atrium Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sarah BoyceDirector2026-09-18126,418$8.95
$1.13MSell
W. Michael FlanaganDirector2026-09-1822,812$8.95
$204.17kSell
Kathleen P. GallagherCEO;Pres2026-09-1811,632$8.95
$104.11kSell
Rocio Martin HoyosCStrat2026-09-188,320$8.95
$74.46kSell
Steven George HughesMed2026-09-1821,459$8.95
$192.06kSell
Stephanie KenneyCXO2026-09-182,375$8.95
$21.26kSell
Brendan R. WinslowCFO2026-09-186,742$8.95
$60.34kSell
Husam YounisCSci2026-09-1811,216$8.95
$100.38kSell

1 of 1

RNA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RNA insiders and whales buy or sell their stock.

RNA Shareholders

What type of owners hold Atrium Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Sarah Boyce0.81%138,668$1.19MInsider
Kathleen P. Gallagher0.70%119,729$1.02MInsider
Steven George Hughes0.30%51,638$441.50kInsider
Husam Younis0.24%41,441$354.32kInsider
Rocio Martin Hoyos0.22%38,340$327.81kInsider
Brendan R. Winslow0.22%36,859$315.14kInsider
Stephanie Kenney0.19%33,085$282.88kInsider
W. Michael Flanagan0.19%31,974$273.38kInsider
Troy Edward Wilson0.07%11,731$100.30kInsider
Carsten Boess0.06%11,005$94.09kInsider

1 of 3

RNA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RNA0.08%3.04%Net SellingNet Selling
VRXA0.00%13.51%Net BuyingNet Buying
MGNX0.08%37.82%Net SellingNet Buying
NGEN0.01%0.00%
TARA0.08%53.58%Net Selling
View Top Biotech Stocks

Atrium Therapeutics Stock Ownership FAQ

Who owns Atrium Therapeutics?

Atrium Therapeutics (NASDAQ: RNA) is owned by 0.08% institutional shareholders, 3.04% Atrium Therapeutics insiders, and 96.87% retail investors. Sarah Boyce is the largest individual Atrium Therapeutics shareholder, owning 138,668.00 shares representing 0.81% of the company. Sarah Boyce's Atrium Therapeutics shares are currently valued at $1.19M.

If you're new to stock investing, here's how to buy Atrium Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.